CUSIP 10806X102COMBBIOQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
429 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Vanguard Group Inc | 16.86M | $1.29B | +30.6K | Added |
| 2 | Blackrock, Inc. | 14.55M | $1.11B | +138.3K | Added |
| 3 | Viking Global Investors LP | 14.39M | $1.10B | −1.58M | Reduced |
| 4 | Kohlberg Kravis Roberts & Co. L.P. | 13.26M | $1.01B |
| 0 |
| Held |
| 5 | Janus Henderson Group PLC | 11.00M | $841.35M | +2.26M | Added |
| 6 | Farallon Capital Management LLC | 9.00M | $688.29M | +806.5K | Added |
| 7 | Aisling Capital Management LP | 5.09M | $389.30M | −1.00M | Reduced |
| 8 | State Street Corp | 4.96M | $379.61M | −643.5K | Reduced |
| 9 | Invesco Ltd. | 4.83M | $369.55M | +902.6K | Added |
| 10 | Geode Capital Management, LLC | 4.41M | $344.69M | +502.6K | Added |
See every fund holding Bridgebio Pharma Inc, with full quarter-over-quarter share changes.
Unlock all holders